SlideShare a Scribd company logo

Managed Access: What Should It Look Like & How Are We Doing

•
•
Canadian Organization for Rare Disorders
Canadian Organization for Rare Disorders

Rare Disease Day 2015 Conference: David Fortier

1 of 2
Managed Access: What Should It Look Like & How Are We Doing David Fortier March 5, 2015
Managed Access: Key Characteristics  Patient centered  Timely  Expert involvement  Process must be “Cost effective”  Pragmatic  Transparent & Accountable  Universal High Quality Access 2

Recommended

Dynamic Pharmacy Patient Support Programs
Dynamic Pharmacy Patient Support ProgramsDynamic Pharmacy Patient Support Programs
Dynamic Pharmacy Patient Support ProgramsSteven Linick
 
Leveraging Patient Support Programs in Biologic-Biosimilar Competitive Landscape
Leveraging Patient Support Programs in Biologic-Biosimilar Competitive LandscapeLeveraging Patient Support Programs in Biologic-Biosimilar Competitive Landscape
Leveraging Patient Support Programs in Biologic-Biosimilar Competitive LandscapeAlex Xiaoguang Zhu
 
Adrian Towse Presentation - Modelling value of early access, 19 May 2015
Adrian Towse Presentation - Modelling value of early access, 19 May 2015Adrian Towse Presentation - Modelling value of early access, 19 May 2015
Adrian Towse Presentation - Modelling value of early access, 19 May 2015Office of Health Economics
 
ROC POP Working with Rare Diseases as Extreme Expressions of Common
ROC POP Working with Rare Diseases as Extreme Expressions of Common ROC POP Working with Rare Diseases as Extreme Expressions of Common
ROC POP Working with Rare Diseases as Extreme Expressions of Common Canadian Organization for Rare Disorders
 
Webinar: Investing $1.5b in A Sustainable Rare Disease Ecosystem
Webinar: Investing $1.5b in A Sustainable Rare Disease EcosystemWebinar: Investing $1.5b in A Sustainable Rare Disease Ecosystem
Webinar: Investing $1.5b in A Sustainable Rare Disease EcosystemCanadian Organization for Rare Disorders
 
CORD-RQMO: English Slides
CORD-RQMO: English Slides CORD-RQMO: English Slides
CORD-RQMO: English Slides Canadian Organization for Rare Disorders
 
CORD-RQMO: French Slides
CORD-RQMO: French SlidesCORD-RQMO: French Slides
CORD-RQMO: French SlidesCanadian Organization for Rare Disorders
 
Webinar: PMPRB NEW Guidelines and Impact on Rare Diseases
Webinar: PMPRB NEW Guidelines and Impact on Rare Diseases Webinar: PMPRB NEW Guidelines and Impact on Rare Diseases
Webinar: PMPRB NEW Guidelines and Impact on Rare Diseases Canadian Organization for Rare Disorders
 

Recommended

Dynamic Pharmacy Patient Support Programs
Dynamic Pharmacy Patient Support ProgramsDynamic Pharmacy Patient Support Programs
Dynamic Pharmacy Patient Support ProgramsSteven Linick
 
Leveraging Patient Support Programs in Biologic-Biosimilar Competitive Landscape
Leveraging Patient Support Programs in Biologic-Biosimilar Competitive LandscapeLeveraging Patient Support Programs in Biologic-Biosimilar Competitive Landscape
Leveraging Patient Support Programs in Biologic-Biosimilar Competitive LandscapeAlex Xiaoguang Zhu
 
Adrian Towse Presentation - Modelling value of early access, 19 May 2015
Adrian Towse Presentation - Modelling value of early access, 19 May 2015Adrian Towse Presentation - Modelling value of early access, 19 May 2015
Adrian Towse Presentation - Modelling value of early access, 19 May 2015Office of Health Economics
 
ROC POP Working with Rare Diseases as Extreme Expressions of Common
ROC POP Working with Rare Diseases as Extreme Expressions of Common ROC POP Working with Rare Diseases as Extreme Expressions of Common
ROC POP Working with Rare Diseases as Extreme Expressions of Common Canadian Organization for Rare Disorders
 
Webinar: Investing $1.5b in A Sustainable Rare Disease Ecosystem
Webinar: Investing $1.5b in A Sustainable Rare Disease EcosystemWebinar: Investing $1.5b in A Sustainable Rare Disease Ecosystem
Webinar: Investing $1.5b in A Sustainable Rare Disease EcosystemCanadian Organization for Rare Disorders
 
CORD-RQMO: English Slides
CORD-RQMO: English Slides CORD-RQMO: English Slides
CORD-RQMO: English Slides Canadian Organization for Rare Disorders
 
CORD-RQMO: French Slides
CORD-RQMO: French SlidesCORD-RQMO: French Slides
CORD-RQMO: French SlidesCanadian Organization for Rare Disorders
 
Webinar: PMPRB NEW Guidelines and Impact on Rare Diseases
Webinar: PMPRB NEW Guidelines and Impact on Rare Diseases Webinar: PMPRB NEW Guidelines and Impact on Rare Diseases
Webinar: PMPRB NEW Guidelines and Impact on Rare Diseases Canadian Organization for Rare Disorders
 
Day 1: NORD Centres of Excellence - Pamela Gavin
Day 1: NORD Centres of Excellence - Pamela GavinDay 1: NORD Centres of Excellence - Pamela Gavin
Day 1: NORD Centres of Excellence - Pamela GavinCanadian Organization for Rare Disorders
 
Day 1: IAM RARE: Pamela Gavin, NORD
Day 1: IAM RARE: Pamela Gavin, NORDDay 1: IAM RARE: Pamela Gavin, NORD
Day 1: IAM RARE: Pamela Gavin, NORDCanadian Organization for Rare Disorders
 
Day 2: Rare Disease & Drug Access Pathway
Day 2: Rare Disease & Drug Access Pathway Day 2: Rare Disease & Drug Access Pathway
Day 2: Rare Disease & Drug Access Pathway Canadian Organization for Rare Disorders
 
Day 2: Thierry Lacaze-Masmonteil, Maternal Infant Child Youth Research Network
Day 2: Thierry Lacaze-Masmonteil, Maternal Infant Child Youth Research NetworkDay 2: Thierry Lacaze-Masmonteil, Maternal Infant Child Youth Research Network
Day 2: Thierry Lacaze-Masmonteil, Maternal Infant Child Youth Research NetworkCanadian Organization for Rare Disorders
 
Dar 2: Patient Engagement and Patient Empowerment Panel
Dar 2: Patient Engagement and Patient Empowerment Panel Dar 2: Patient Engagement and Patient Empowerment Panel
Dar 2: Patient Engagement and Patient Empowerment Panel Canadian Organization for Rare Disorders
 
Day 2: Cheryl Greenberg, Children's Hospital Research Institute of Manitoba
Day 2: Cheryl Greenberg, Children's Hospital Research Institute of ManitobaDay 2: Cheryl Greenberg, Children's Hospital Research Institute of Manitoba
Day 2: Cheryl Greenberg, Children's Hospital Research Institute of ManitobaCanadian Organization for Rare Disorders
 
Day 1: INFORM RARE: Beth Potter, Alexandra Wyatt, Pranesh Chakraborty, Monica...
Day 1: INFORM RARE: Beth Potter, Alexandra Wyatt, Pranesh Chakraborty, Monica...Day 1: INFORM RARE: Beth Potter, Alexandra Wyatt, Pranesh Chakraborty, Monica...
Day 1: INFORM RARE: Beth Potter, Alexandra Wyatt, Pranesh Chakraborty, Monica...Canadian Organization for Rare Disorders
 
Day 1: Newborn Screening: Pranesh Chakraborty, University of Ottawa
Day 1: Newborn Screening: Pranesh Chakraborty, University of OttawaDay 1: Newborn Screening: Pranesh Chakraborty, University of Ottawa
Day 1: Newborn Screening: Pranesh Chakraborty, University of OttawaCanadian Organization for Rare Disorders
 
Day 1: Phenotypes: Orion Buske, PhenoTips
Day 1: Phenotypes: Orion Buske, PhenoTipsDay 1: Phenotypes: Orion Buske, PhenoTips
Day 1: Phenotypes: Orion Buske, PhenoTipsCanadian Organization for Rare Disorders
 
Day 1: Genomic Sequencing: Kym Boycott, CHEO
Day 1: Genomic Sequencing: Kym Boycott, CHEODay 1: Genomic Sequencing: Kym Boycott, CHEO
Day 1: Genomic Sequencing: Kym Boycott, CHEOCanadian Organization for Rare Disorders
 
Day 1: INFORM RARE
Day 1: INFORM RAREDay 1: INFORM RARE
Day 1: INFORM RARECanadian Organization for Rare Disorders
 
Day 1 : Canadian Neuromuscular Network, Western University - Craig Campbell, ...
Day 1 : Canadian Neuromuscular Network, Western University - Craig Campbell, ...Day 1 : Canadian Neuromuscular Network, Western University - Craig Campbell, ...
Day 1 : Canadian Neuromuscular Network, Western University - Craig Campbell, ...Canadian Organization for Rare Disorders
 
Day 1: Rare Disease Research Network and National Children’s Hospital - Marsh...
Day 1: Rare Disease Research Network and National Children’s Hospital - Marsh...Day 1: Rare Disease Research Network and National Children’s Hospital - Marsh...
Day 1: Rare Disease Research Network and National Children’s Hospital - Marsh...Canadian Organization for Rare Disorders
 
Day 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
Day 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDISDay 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
Day 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDISCanadian Organization for Rare Disorders
 
Day 1: Children's Healthcare Canada CORD
Day 1: Children's Healthcare Canada CORD Day 1: Children's Healthcare Canada CORD
Day 1: Children's Healthcare Canada CORD Canadian Organization for Rare Disorders
 
Day 1: Network of Centres of Excellence
Day 1: Network of Centres of ExcellenceDay 1: Network of Centres of Excellence
Day 1: Network of Centres of ExcellenceCanadian Organization for Rare Disorders
 
Day 1: Status of Canadian access for RD drugs Panel
Day 1: Status of Canadian access for RD drugs Panel Day 1: Status of Canadian access for RD drugs Panel
Day 1: Status of Canadian access for RD drugs Panel Canadian Organization for Rare Disorders
 
Day 1: Patient Experiences
Day 1: Patient ExperiencesDay 1: Patient Experiences
Day 1: Patient ExperiencesCanadian Organization for Rare Disorders
 
Day 1: Real-World Data Panel
Day 1: Real-World Data Panel Day 1: Real-World Data Panel
Day 1: Real-World Data Panel Canadian Organization for Rare Disorders
 
Day 1: KHURE Health: Don Watts, KHURE
Day 1: KHURE Health: Don Watts, KHUREDay 1: KHURE Health: Don Watts, KHURE
Day 1: KHURE Health: Don Watts, KHURECanadian Organization for Rare Disorders
 

More Related Content

More from Canadian Organization for Rare Disorders

Day 2: Thierry Lacaze-Masmonteil, Maternal Infant Child Youth Research Network
Day 2: Thierry Lacaze-Masmonteil, Maternal Infant Child Youth Research NetworkDay 2: Thierry Lacaze-Masmonteil, Maternal Infant Child Youth Research Network
Day 2: Thierry Lacaze-Masmonteil, Maternal Infant Child Youth Research NetworkCanadian Organization for Rare Disorders
 
Day 2: Cheryl Greenberg, Children's Hospital Research Institute of Manitoba
Day 2: Cheryl Greenberg, Children's Hospital Research Institute of ManitobaDay 2: Cheryl Greenberg, Children's Hospital Research Institute of Manitoba
Day 2: Cheryl Greenberg, Children's Hospital Research Institute of ManitobaCanadian Organization for Rare Disorders
 
Day 1: INFORM RARE: Beth Potter, Alexandra Wyatt, Pranesh Chakraborty, Monica...
Day 1: INFORM RARE: Beth Potter, Alexandra Wyatt, Pranesh Chakraborty, Monica...Day 1: INFORM RARE: Beth Potter, Alexandra Wyatt, Pranesh Chakraborty, Monica...
Day 1: INFORM RARE: Beth Potter, Alexandra Wyatt, Pranesh Chakraborty, Monica...Canadian Organization for Rare Disorders
 
Day 1 : Canadian Neuromuscular Network, Western University - Craig Campbell, ...
Day 1 : Canadian Neuromuscular Network, Western University - Craig Campbell, ...Day 1 : Canadian Neuromuscular Network, Western University - Craig Campbell, ...
Day 1 : Canadian Neuromuscular Network, Western University - Craig Campbell, ...Canadian Organization for Rare Disorders
 
Day 1: Rare Disease Research Network and National Children’s Hospital - Marsh...
Day 1: Rare Disease Research Network and National Children’s Hospital - Marsh...Day 1: Rare Disease Research Network and National Children’s Hospital - Marsh...
Day 1: Rare Disease Research Network and National Children’s Hospital - Marsh...Canadian Organization for Rare Disorders
 

More from Canadian Organization for Rare Disorders (20)

Day 1: NORD Centres of Excellence - Pamela Gavin
Day 1: NORD Centres of Excellence - Pamela GavinDay 1: NORD Centres of Excellence - Pamela Gavin
Day 1: NORD Centres of Excellence - Pamela Gavin
 
Day 1: IAM RARE: Pamela Gavin, NORD
Day 1: IAM RARE: Pamela Gavin, NORDDay 1: IAM RARE: Pamela Gavin, NORD
Day 1: IAM RARE: Pamela Gavin, NORD
 
Day 2: Rare Disease & Drug Access Pathway
Day 2: Rare Disease & Drug Access Pathway Day 2: Rare Disease & Drug Access Pathway
Day 2: Rare Disease & Drug Access Pathway
 
Day 2: Thierry Lacaze-Masmonteil, Maternal Infant Child Youth Research Network
Day 2: Thierry Lacaze-Masmonteil, Maternal Infant Child Youth Research NetworkDay 2: Thierry Lacaze-Masmonteil, Maternal Infant Child Youth Research Network
Day 2: Thierry Lacaze-Masmonteil, Maternal Infant Child Youth Research Network
 
Dar 2: Patient Engagement and Patient Empowerment Panel
Dar 2: Patient Engagement and Patient Empowerment Panel Dar 2: Patient Engagement and Patient Empowerment Panel
Dar 2: Patient Engagement and Patient Empowerment Panel
 
Day 2: Cheryl Greenberg, Children's Hospital Research Institute of Manitoba
Day 2: Cheryl Greenberg, Children's Hospital Research Institute of ManitobaDay 2: Cheryl Greenberg, Children's Hospital Research Institute of Manitoba
Day 2: Cheryl Greenberg, Children's Hospital Research Institute of Manitoba
 
Day 1: INFORM RARE: Beth Potter, Alexandra Wyatt, Pranesh Chakraborty, Monica...
Day 1: INFORM RARE: Beth Potter, Alexandra Wyatt, Pranesh Chakraborty, Monica...Day 1: INFORM RARE: Beth Potter, Alexandra Wyatt, Pranesh Chakraborty, Monica...
Day 1: INFORM RARE: Beth Potter, Alexandra Wyatt, Pranesh Chakraborty, Monica...
 
Day 1: Newborn Screening: Pranesh Chakraborty, University of Ottawa
Day 1: Newborn Screening: Pranesh Chakraborty, University of OttawaDay 1: Newborn Screening: Pranesh Chakraborty, University of Ottawa
Day 1: Newborn Screening: Pranesh Chakraborty, University of Ottawa
 
Day 1: Phenotypes: Orion Buske, PhenoTips
Day 1: Phenotypes: Orion Buske, PhenoTipsDay 1: Phenotypes: Orion Buske, PhenoTips
Day 1: Phenotypes: Orion Buske, PhenoTips
 
Day 1: Genomic Sequencing: Kym Boycott, CHEO
Day 1: Genomic Sequencing: Kym Boycott, CHEODay 1: Genomic Sequencing: Kym Boycott, CHEO
Day 1: Genomic Sequencing: Kym Boycott, CHEO
 
Day 1: INFORM RARE
Day 1: INFORM RAREDay 1: INFORM RARE
Day 1: INFORM RARE
 
Day 1 : Canadian Neuromuscular Network, Western University - Craig Campbell, ...
Day 1 : Canadian Neuromuscular Network, Western University - Craig Campbell, ...Day 1 : Canadian Neuromuscular Network, Western University - Craig Campbell, ...
Day 1 : Canadian Neuromuscular Network, Western University - Craig Campbell, ...
 
Day 1: Rare Disease Research Network and National Children’s Hospital - Marsh...
Day 1: Rare Disease Research Network and National Children’s Hospital - Marsh...Day 1: Rare Disease Research Network and National Children’s Hospital - Marsh...
Day 1: Rare Disease Research Network and National Children’s Hospital - Marsh...
 
Day 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
Day 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDISDay 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
Day 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
 
Day 1: Children's Healthcare Canada CORD
Day 1: Children's Healthcare Canada CORD Day 1: Children's Healthcare Canada CORD
Day 1: Children's Healthcare Canada CORD
 
Day 1: Network of Centres of Excellence
Day 1: Network of Centres of ExcellenceDay 1: Network of Centres of Excellence
Day 1: Network of Centres of Excellence
 
Day 1: Status of Canadian access for RD drugs Panel
Day 1: Status of Canadian access for RD drugs Panel Day 1: Status of Canadian access for RD drugs Panel
Day 1: Status of Canadian access for RD drugs Panel
 
Day 1: Patient Experiences
Day 1: Patient ExperiencesDay 1: Patient Experiences
Day 1: Patient Experiences
 
Day 1: Real-World Data Panel
Day 1: Real-World Data Panel Day 1: Real-World Data Panel
Day 1: Real-World Data Panel
 
Day 1: KHURE Health: Don Watts, KHURE
Day 1: KHURE Health: Don Watts, KHUREDay 1: KHURE Health: Don Watts, KHURE
Day 1: KHURE Health: Don Watts, KHURE
 

Managed Access: What Should It Look Like & How Are We Doing